|
Home /
Takeda Pharmaceutical
Takeda Pharmaceutical
 Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a
leading global pharmaceutical company, research based and the largest
pharmaceutical company in Japan, with marketing operations in around 90
countries worldwide.
Takeda Pharmaceutical was founded by Chobei Takeda
in 1781, with one small shop selling traditional Japanese and Chinese
medicines. These were the humble biginnings of the present day Company. It was
over 100 years later that the Company opened it's own pharmaceutical
manufacturing factory in 1895. Early Takeda Pharmaceutical products included
bismuth subgallate and quinine hydrochloride.
Takeda Pharmaceutical products
Ethical pharmaceuticals is Takeda's core
focus and in such areas as cardiovascular, diabetes, endometriosis, oncology
and gastrointestinal. The Takeda pharmaceutical portfolio includes:
Pioglitazone Hydrochloride (diabetes), Candesartan Cilexetil (hypertension),
Lansoproazole (peptic ulcers) and Leuprorelin Acetate (prostate cancer and
endometriosis).
Takeda branded pharmaceuticals
Takeda branded pharmaceuticals include:
ACTOS®, BASEN®, BLOPRESS®, CALSLOT®, ADECUT®,
PREVACID®, OSTEN®, BENET®, PANSPORIN®, FIRSTCIN®,
BESTCALL®, TAKESULIN®, AMASULIN®, PANSPORIN T®, CELEUK®,
NICHOLIN®, HIRTONIN®, EURODIN®, DASEN®, BRONICA® and
SOLFA®.
Takeda Consumer Healthcare Products
Takeda has Consumer Healthcare operation in
Japan within the over-the-counter (OTC) drug market. Areas covered include:
Cold Remedies, Gastrointestinal Drugs, Vitamin Products, Athlete's Foot
Treatments and Laxatives.
Latest Takeda Pharmaceutical news
Takeda and Alnylam - Billion-dollar deals. Amgen and Takeda - Billion-dollar deals. DPP-4 inhibitors get spotlight at ADA meeting. Takeda gains RNAi tech with $1B Alnylam deal. Mass. biotechs ripe for buyouts. ALSO NOTED: Antisoma gets $25M milestone; Takeda pays out retention bonuses; and much more.... Takeda makes $8.8B bid for Millennium. Takeda makes $8.8B bid for Millennium. Cell Genesys scores $320M blockbuster deal. Safety, efficacy problems sink Takeda drug. Antiosteoporotic drugs âActonel® 17.5 mg tabletsâ and âBenet® 17.5 mg tabletsâ received approval for additional indication in patients with Pagetâs disease of bone: Both come in new packages.. Notice Concerning the Determination of the Items of Stock Options (Stock Acquisition Rights) for Members of the Board of Directors. Takeda Submitted a Request for Mutual Agreement Procedure Regarding a Correction Notice Based on Transfer Pricing Taxation. Takeda Pharmaceuticals and TAP Pharmaceutical Products Inc. MergeCombined Company is a Top 15 Pharmaceutical Company in the United States. Launch of âENBREL® 25mg Syringe 0.5 mL for S.C. InjectionâNew Formulation of ENBREL®. read more
Takeda Pharmaceutical further information:
www.takeda.com /
www.takeda.co.uk/ / Takeda Pharmaceutical news
Page last updated:
09/06/08 |
